Related Experiment Video
Updated: Jun 5, 2026

Measuring Composition of CD95 Death-Inducing Signaling Complex and Processing of Procaspase-8 in this Complex
Published on: August 2, 2021
F-box protein 10, an NF-κB-dependent anti-apoptotic protein, regulates TRAIL-induced apoptosis through modulating
1Department of Urology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Abstract:
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces selective apoptotic death of human cancer cells while sparing normal human cells. Although TRAIL holds great promise as a potential anticancer agent, some tumors develop resistance to TRAIL. Previously, we have shown that the activator protein 1 (AP-1) family member, c-Fos, is an important modulator of apoptosis. Although F- box protein 10 (FBXL10) has been implicated to regulate an AP-1 family protein, c-Jun, its role in mediating apoptotic pathways has not been previously investigated. Here, we report that FBXL10 is a transcriptional repressor of c-Fos and a target gene of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB)-p65 in human cancers. We demonstrate that FBXL10 is an important anti-apoptotic molecule, which directly binds and represses c-Fos promoter in order for cancer cells to resist TRAIL-induced apoptosis. FBXL10 indirectly regulates c-FLIP(L) levels via c-Fos-dependent pathways. Silencing of FBXL10 sensitizes resistant cells to TRAIL, while, overexpression of FBXL10 represses TRAIL-induced apoptosis. Moreover, our results indicate that expression of FBXL10 functions via an NF-κB-dependent pathway, and TRAIL or proteasome inhibitors downregulate FBXL10 via inhibiting NF-κB signaling. Taken together, we find a novel functional role for FBXL10 as an anti-apoptotic molecule, and describe a new apoptotic-related pathway that involves NF-κB/FBXL10/c-Fos/c-FLIP. Therefore, silencing FBXL10 can help overcome resistant cancer cells for pro-apoptotic therapies.
Insights
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) resistance in cancer can be overcome by targeting FBXL10. This study reveals FBXL10 as an anti-apoptotic molecule that silences c-Fos, promoting cancer cell survival against TRAIL therapy.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Death Pathways
Background:
- Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces cancer cell death but resistance is a challenge.
- Activating transcription factor 3 (ATF3) and activating transcription factor 4 (ATF4) are stress-inducible transcription factors.
- F-box protein 10 (FBXL10) has been implicated in regulating AP-1 family proteins, but its role in apoptosis is unclear.
Purpose of the Study:
- Investigate the role of FBXL10 in mediating resistance to TRAIL-induced apoptosis.
- Elucidate the molecular mechanisms by which FBXL10 affects apoptotic pathways.
- Identify potential therapeutic strategies to overcome TRAIL resistance in cancer.
Main Methods:
- Western blotting to assess protein levels.
- Luciferase reporter assays to study transcriptional activity.
- Quantitative real-time PCR to measure gene expression.
- Chromatin immunoprecipitation to analyze protein-DNA interactions.
- Cell viability assays to evaluate apoptosis.
Main Results:
- FBXL10 acts as a transcriptional repressor of c-Fos, a key apoptosis regulator.
- FBXL10 expression is regulated by NF-κB-p65 and contributes to TRAIL resistance.
- Silencing FBXL10 sensitizes resistant cancer cells to TRAIL, while its overexpression promotes resistance.
- FBXL10 indirectly modulates c-FLIP(L) levels through c-Fos-dependent pathways.
- TRAIL and proteasome inhibitors downregulate FBXL10 by inhibiting NF-κB signaling.
Conclusions:
- FBXL10 is a novel anti-apoptotic molecule that promotes cancer cell resistance to TRAIL.
- A new apoptotic pathway involving NF-κB/FBXL10/c-Fos/c-FLIP is identified.
- Targeting FBXL10 presents a promising strategy to enhance the efficacy of TRAIL-based cancer therapies.
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-kB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Apoptosis
Caspases

